Neuroendocrine Tumor of the Lung


Wasat Mansoor of The Christie NHS Foundation Trust in the United Kingdom presents a discussion on the management of bronchial neuroendocrine tumors.
Learn more: https://www.ctsnet.org/article..../management-and-foll
The Cardiothoracic Surgery Network (CTSNet) connects the global cardiothoracic community through communication, collaboration, education, and interaction amongst cardiothoracic surgeons and their teams across the globe. CTSNet provides a broad range of video and text-based educational content, the premier job board across all of cardiothoracic surgery, profile pages for cardiothoracic surgeons and individuals associated with the specialty, and a calendar of events related to the specialty.
Find even more content on our website:
https://www.ctsnet.org/
Connect with us on Facebook:
https://www.facebook.com/CTSNet/
Connect with us on Twitter:
https://twitter.com/ctsnetorg


Los Angeles Carcinoid Neuroendocrine Tumor Society (LACNETS)
Patient Education Seminar
April 14, 2015
Comprehensive Transplant Center @ Cedars-Sinai
info@LACNETS.org
Deepti Dhall, MD
Pathologist
Cedars-Sinai Medical Center
Full transcription available as PDF HERE: http://bit.ly/LACNETS_Dhall_Transcription_20150414
Ziva Naghiyeva, LCSW
Giovanna Imbesi, MBA
Executive Director, Generate Possibility
Music by Giovanna Joyce Imbesi


Thor Halfdanarson, MD, medical oncologist at Mayo Clinic, discusses his takeaway message on neuroendocrine tumors (NETs) at the 2018 ISGIO Annual Conference.
Halfdanarson oeps that community oncologists understand that not all grade 3 or high-grade NETs are the same, nor should they be treated the same. There is, for example, a subset of patients with high-grade NETs that needs to be treated aggressively with cytotoxic chemotherapy, while another subset does not require such aggressive, upfront therapy.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/